Literature DB >> 22368520

A Tuber-ful Animal Model of Tuberous Sclerosis At Last?

Michael Wong.   

Abstract

Entities:  

Year:  2012        PMID： 22368520      PMCID： PMC3280466          DOI： 10.5698/1535-7511-12.1.15

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  10 in total

1.  Biallelic TSC gene inactivation in tuberous sclerosis complex.

Authors:  Peter B Crino; Eleonora Aronica; Gordon Baltuch; Katherine L Nathanson
Journal:  Neurology       Date:  2010-05-25       Impact factor: 9.910

2.  The utility of tuberless models of tuberous sclerosis.

Authors:  Michael Wong
Journal:  Epilepsia       Date:  2007-08       Impact factor: 5.864

3.  Novel cerebral lesions in the Eker rat model of tuberous sclerosis: cortical tuber and anaplastic ganglioglioma.

Authors:  M Mizuguchi; S Takashima; H Yamanouchi; Y Nakazato; H Mitani; O Hino
Journal:  J Neuropathol Exp Neurol       Date:  2000-03       Impact factor: 3.685

4.  Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice.

Authors:  David M Feliciano; Tiffany Su; Jean Lopez; Jean-Claude Platel; Angélique Bordey
Journal:  J Clin Invest       Date:  2011-03-14       Impact factor: 14.808

5.  Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events.

Authors:  Wei Qin; Jennifer A Chan; Harry V Vinters; Gary W Mathern; David N Franz; Bruce E Taillon; Pascal Bouffard; David J Kwiatkowski
Journal:  Brain Pathol       Date:  2010-07-13       Impact factor: 6.508

6.  Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures.

Authors:  Erik J Uhlmann; Michael Wong; Rebecca L Baldwin; M Livia Bajenaru; Hiroaki Onda; David J Kwiatkowski; Kelvin Yamada; David H Gutmann
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

7.  Surgical outcome in tuberous sclerosis complex: a multicenter survey.

Authors:  Deepak Madhavan; Sarah Schaffer; Alexei Yankovsky; Alexis Arzimanoglou; Florence Renaldo; Charles M Zaroff; Josiane LaJoie; Howard L Weiner; Eva Andermann; David N Franz; Jennifer Leonard; Mary Connolly; Greg D Cascino; Orrin Devinsky
Journal:  Epilepsia       Date:  2007-05-01       Impact factor: 5.864

8.  Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.

Authors:  Lynsey Meikle; Kristen Pollizzi; Anna Egnor; Ioannis Kramvis; Heidi Lane; Mustafa Sahin; David J Kwiatkowski
Journal:  J Neurosci       Date:  2008-05-21       Impact factor: 6.167

9.  Are cortical tubers epileptogenic? Evidence from electrocorticography.

Authors:  Philippe Major; Sonja Rakowski; Mirela V Simon; Ming L Cheng; Emad Eskandar; Joshua Baron; Beth A Leeman; Matthew P Frosch; Elizabeth A Thiele
Journal:  Epilepsia       Date:  2009-01       Impact factor: 5.864

10.  Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.

Authors:  Sharon W Way; James McKenna; Ulrike Mietzsch; R Michelle Reith; Henry Cheng-Ju Wu; Michael J Gambello
Journal:  Hum Mol Genet       Date:  2009-01-15       Impact factor: 6.150
  10 in total
  2 in total

Review 1.  A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.

Authors:  David M Feliciano; Tiffany V Lin; Nathaniel W Hartman; Christopher M Bartley; Cathryn Kubera; Lawrence Hsieh; Carlos Lafourcade; Rachel A O'Keefe; Angelique Bordey
Journal:  Int J Dev Neurosci       Date:  2013-02-26       Impact factor: 2.457

Review 2.  Modeling neurological disorders using brain organoids.

Authors:  Daniel Y Zhang; Hongjun Song; Guo-Li Ming
Journal:  Semin Cell Dev Biol       Date:  2020-06-17       Impact factor: 7.727
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.